Bollinger Innovations, Inc.: Form 10-Q/A for the period ended Mar 31, 2022
Filed with the SEC on May 17, 2022 and accepted by EDGAR at May 17, 2022, 13:26 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2022-01-01 to 2022-03-31 | $1.2m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2021-10-01 to 2022-03-31 | $2.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2022-01-01 to 2022-03-31 | −$30.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2021-10-01 to 2022-03-31 | −$44.5m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2022-01-01 to 2022-03-31 | −$32.6m | us-gaap:NetIncomeLoss |
| Net income | 6 months2021-10-01 to 2022-03-31 | −$69.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-01-01 to 2022-03-31 | −$0.63 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2021-10-01 to 2022-03-31 | −$1.99 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-01-01 to 2022-03-31 | −$0.63 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2021-10-01 to 2022-03-31 | −$1.99 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-01-01 to 2022-03-31 | 51,392,988 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2021-10-01 to 2022-03-31 | 34,639,857 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2021-10-01 to 2022-03-31 | −$24.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2021-10-01 to 2022-03-31 | $10.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2022-03-31 | $65.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-03-31 | $83.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-03-31 | $105.2m | us-gaap:Assets |
| Current liabilities | At period end2022-03-31 | $43.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-03-31 | $55.6m | us-gaap:Liabilities |
| Long-term debt | At period end2022-03-31 | $5.2m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2022-03-31 | $16.9m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2022-03-31 | $49.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001558370-22-009134. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.